Nordic Capital acquires BWXT Medical Business
The transaction, valued at up to $800 million, includes BWXT Medical and Kinectrics’ stable medical isotopes operations.
Takeaways
- BWXT Medical Business is a radiopharmaceutical and medical isotopes business.
- Nordic Capital is acquiring BWXT Medical Business.
- The business serves healthcare (radiopharmaceuticals).
BWX Technologies is carving out its radiopharmaceutical and medical isotopes business, selling the unit to Nordic Capital in a deal valued at up to $800 million.
The divested operations include BWXT Medical, a provider of diagnostic and therapeutic radiopharmaceuticals, and Kinectrics’ stable medical isotopes business, which supplies isotopes for medical imaging and research applications.
Nordic Capital, an experienced healthcare investor, views the acquisition as a foundation to build a broader radiopharmaceutical platform.
Get Buyout Desk email updates.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up on the site. Email updates are not on a fixed schedule.